Celgene (CELG) Tops Q4 EPS by 3c, FY Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Celgene (CELG) PT Raised to $105 at Piper Jaffray
January 26, 2018 9:02 AM ESTPiper Jaffray raised its price target on Celgene (NASDAQ: CELG) to $105.00 (from $104.00) while maintaining a Neutral rating.
... MoreCelgene (CELG) PT Raised to $135 at Leerink Partners Following 4Q
January 26, 2018 7:14 AM ESTLeerink Partners raised its price target on Celgene (NASDAQ: CELG) to $135.00 (from $129.00) while maintaining a Outperform rating. Yesterday Celgene confirmed their previously announced Q4 results and reaffirmed their 2018 product revenue and operating guidance.
Total revenue was in-line with consensus at $3.48bn and adjusted... More
